For Sammy Kolt, no two days are alike as he combines his passion for people with his enthusiasm about operations and enablement. He filled several different roles at Aptean, a great benefit when it comes to leading Portfolio Operations - a group that encompasses a number of very different areas from product management to M&A integrations to Customer Success.
Aptean welcomed veteran marketing expert Leo Tucker as the company’s new Chief Marketing Officer. We sat down with Leo to chat about his background, his early impressions of Aptean, and how he spends his time outside the office.
Q: Leo, can you start by telling us about your background and the path that brought you to Aptean?
The system for collecting value-added tax (VAT) in the European Union has always had its critics. When the European Commission announced its VAT action plan in 2016, part of their stated ambition was to make the current EU VAT system simpler to use and, as a result, more business-friendly.
The Spanish government is responding to the challenges of the Commission's action plan by further strengthening measures to reduce the VAT gap by applying a strategy to modernize VAT administration, through the introduction of a new system incorporating the "Immediate Supply of Information" (SII). SII is another key step in the process of continuous improvement the Spanish authorities are undertaking. The mission involves upgrading systems and creating the system of the future. The government's intention is to improve the information they gather, both to gain more effective control of the system and to focus on generating more revenue.
In this whitepaper, Jaume Carol, Senior Manager Customer Solutions, breaks down who will be affected and what needs to be considered when selecting a financial management solution.
Both of the NHS England initiatives (Clinical Utilisation Review and SAFER) cite evidence that patients deteriorate physically and cognitively in direct proportion to their length of stay; and for elderly patients this has a significant impact on life-expectancy. Their common goal is to minimise inappropriate delays to ensure Safe, Rapid Discharge or Transition of Patients and to avoid unnecessary hospital stays at an inappropriate level of care.
In this whitepaper, Peter Ellis, Managing Director Medworxx UK, discusses how both Clinical Utilisation Review (CUR) and SAFER (RED2GREEN days) intend to provide transparency and rigour to managing the patient's journey to ensure, at a minimum, daily assessment of key activities and status. These initiatives are interdependent and if appropriately integrated and harnessed, provide a comprehensive picture of the appropriateness of days of care across the organisation.